Top

Reactions Weekly

Published in:

01-05-2020 | Cutaneous Squamous Cell Carcinoma | Case report

Pembrolizumab

Eruptive porokeratosis: case report

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Maredia H, et al. Eruptive porokeratosis during pembrolizumab treatment of invasive cutaneous squamous cell carcinoma. International Journal of Dermatology 59: e141-e142, No. 5, May 2020. Available from: URL: http://doi.org/10.1111/ijd.14701

Title: Pembrolizumab
Eruptive porokeratosis: case report
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Cutaneous Squamous Cell Carcinoma
Porokeratosis
Cutaneous Squamous Cell Carcinoma
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78951-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Eruptive porokeratosis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Cefepime

Pembrolizumab

Ibuprofen/bromisoval/ethenzamide/caffeine

Methadone/naltrexone/oxycodone

Efavirenz

Parenteral-nutrition-supplements/propofol